PEDIATRICS Vol. 115 No. 4 April 2005, pp. 926-936 (doi:10.1542/peds.2004-1209)
Neonatal Ventilation With Inhaled Nitric Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure: The INNOVO Multicentre Randomised Controlled Trial (ISRCTN 17821339)








* Department of Health Science, Leicester Royal Infirmary, Leicester, United Kingdom
Medical Statistics Unit, London School of Hygiene and Tropical Medicine, London, United Kingdom
Health Services Research Unit, London School of Hygiene and Tropical Medicine, London, United Kingdom
|| Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom
¶ Liverpool Women's Hospital, Liverpool, United Kingdom
# Rosie Hospital, Cambridge, United Kingdom
** Royal Maternity Hospital, Belfast, Republic of Ireland

Institute of Child Health, London, United Kingdom
Background. Although inhaled nitric oxide (iNO) may be a promising treatment for newborn infants with severe respiratory failure, the results from 3 previous small trials were inconclusive.
Methods. Infants of <34 weeks' gestation, <28 days old, and with severe respiratory failure requiring ventilatory support were randomized to receive or not receive iNO. The study was not blinded.
Findings. Recruited were 108 infants (55 allocated to receive iNO and 53 not allocated to receive iNO) from 15 neonatal units in the United Kingdom and Republic of Ireland. Fifty-nine percent (64 of 108) died, and 84% of the survivors (37 of 44) had signs of some impairment or disability, 9 (20%) of them classified as severely disabled. There was no evidence of an effect of iNO on the primary outcomes: death or severe disability at 1 year corrected age (relative risk [RR]: 0.99; 95% confidence interval [CI]: 0.76 to 1.29); death or supplemental oxygen on expected date of delivery (RR: 0.84; 95% CI: 0.68 to 1.02); or death or supplemental oxygen at 36 weeks' postmenstrual age (RR: 0.98; 95% CI: 0.87 to 1.12). There was a trend for infants allocated to the iNO group to spend more time on the ventilator (log rank: 3.6), on supplemental oxygen (log rank: 1.4), and in hospital (log rank: 3.5) than those allocated to receive no iNO. This pattern predominantly reflected the infants who died. Mean total costs at 1 year corrected age were significantly higher in the iNO group, partly because of the costs of the gas but mainly because of the difference in initial hospitalization costs.
Interpretation. Evidence of prolongation of intensive care and increased costs of such care, without clear beneficial effects, implies that iNO cannot be recommended for preterm infants with severe hypoxic respiratory failure.
Key Words: neonatal intensive care nitric oxide ventilation preterm infants
Abbreviations: NO, nitric oxide iNO, inhaled nitric oxide INNOVO, Neonatal Ventilation With Inhaled Nitric Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure OI, oxygenation index PaO2, partial pressure of oxygen, arterial NHS, National Health Service RR, relative risk CI, confidence interval DMC, data-monitoring committee
Accepted Aug 25, 2004.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
A. Bhandari and V. Bhandari Pitfalls, Problems, and Progress in Bronchopulmonary Dysplasia Pediatrics, June 1, 2009; 123(6): 1562 - 1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
C L Huddy, C C Bennett, P Hardy, D Field, D Elbourne, R Grieve, A Truesdale, K Diallo, and on behalf of the INNOVO Trial Collaborating Group The INNOVO multicentre randomised controlled trial: neonatal ventilation with inhaled nitric oxide versus ventilatory support without nitric oxide for severe respiratory failure in preterm infants: follow up at 4-5 years Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2008; 93(6): F430 - F435. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Ballard, W. E. Truog, J. D. Merrill, A. Gow, M. Posencheg, S. G. Golombek, L. A. Parton, X. Luan, A. Cnaan, and R. A. Ballard Plasma Biomarkers of Oxidative Stress: Relationship to Lung Disease and Inhaled Nitric Oxide Therapy in Premature Infants Pediatrics, March 1, 2008; 121(3): 555 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Barrington and N. N. Finer Inhaled Nitric Oxide for Preterm Infants: A Systematic Review Pediatrics, November 1, 2007; 120(5): 1088 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Subhedar and C. Dewhurst Is nitric oxide effective in preterm infants? Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2007; 92(5): F337 - F341. [Full Text] [PDF] |
||||
![]() |
P. L. Ballard, J. D. Merrill, W. E. Truog, R. I. Godinez, M. H. Godinez, T. M. McDevitt, Y. Ning, S. G. Golombek, L. A. Parton, X. Luan, et al. Surfactant Function and Composition in Premature Infants Treated With Inhaled Nitric Oxide Pediatrics, August 1, 2007; 120(2): 346 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Bloch, F. Ichinose, J. D. Roberts Jr., and W. M. Zapol Inhaled NO as a therapeutic agent Cardiovasc Res, July 15, 2007; 75(2): 339 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Steinhorn and J. P. Kinsella Pharmacology Review: Use of Inhaled Nitric Oxide in the Preterm Infant NeoReviews, June 1, 2007; 8(6): e247 - e253. [Abstract] [Full Text] [PDF] |
||||
![]() |
Perinatal medicine Arch. Dis. Child., April 1, 2007; 92(suppl_1): A39 - A41. [Full Text] [PDF] |
||||
![]() |
D. Wilson-Costello, H. Friedman, N. Minich, B. Siner, G. Taylor, M. Schluchter, and M. Hack Improved Neurodevelopmental Outcomes for Extremely Low Birth Weight Infants in 2000-2002 Pediatrics, January 1, 2007; 119(1): 37 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sheffield, S. Mabry, D. W. Thibeault, and W. E. Truog Pulmonary Nitric Oxide Synthases and Nitrotyrosine: Findings During Lung Development and in Chronic Lung Disease of Prematurity Pediatrics, September 1, 2006; 118(3): 1056 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Ballard, W. E. Truog, A. Cnaan, R. J. Martin, P. L. Ballard, J. D. Merrill, M. C. Walsh, D. J. Durand, D. E. Mayock, E. C. Eichenwald, et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N. Engl. J. Med., July 27, 2006; 355(4): 343 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Martin and M. C. Walsh Inhaled Nitric Oxide for Preterm Infants -- Who Benefits? N. Engl. J. Med., July 7, 2005; 353(1): 82 - 84. [Full Text] [PDF] |
||||










